Literature DB >> 26393431

MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.

Panchanan Maiti1, Laura C Gregg1, Michael P McDonald2.   

Abstract

In Parkinson's disease, cognitive deficits manifest as fronto-striatally-mediated executive dysfunction, with impaired attention, planning, judgment, and impulse control. We examined changes in executive function in mice lesioned with subchronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using a 3-choice serial reaction-time (SRT) task, which included measures of sustained attention and impulse control. Each trial of the baseline SRT task comprised a pseudo-random pre-cue period ranging from 3 to 8 s, followed by a 1-s cue duration. MPTP impaired all measures of impulsive behavior acutely, but with additional training their performance normalized to saline control levels. When challenged with shorter cue durations, MPTP-lesioned mice had significantly slower reaction times than wild-type mice. When challenged with longer pre-cue times, the MPTP-lesioned mice exhibited a loss of impulse control at the longer durations. In lesioned mice, striatal dopamine was depleted by 54% and the number of tyrosine-hydroxylase-positive neurons in the substantia nigra pars compacta was reduced by 75%. Serotonin (5-HT) was unchanged in the striatum and prefrontal cortex (PFC), but the ratio of 5-hydroxyindolacetic acid (5-HIAA) to 5-HT was significantly reduced in the MPTP group in the PFC. In lesioned mice, prefrontal 5-HIAA/5-HT was significantly correlated with the executive impairments and striatal norepinephrine was associated with slower reaction times. None of the neurochemical measures was significantly associated with behavior in saline-treated controls. Taken together, these results show that prefrontal 5-HT turnover may play a pivotal role in MPTP-induced executive dysfunction.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Executive function; Impulse control; MPTP; Mice; Parkinson’s disease; Sustained attention

Mesh:

Substances:

Year:  2015        PMID: 26393431      PMCID: PMC4803113          DOI: 10.1016/j.bbr.2015.09.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  68 in total

1.  Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops.

Authors:  Saori C Tanaka; Kenji Doya; Go Okada; Kazutaka Ueda; Yasumasa Okamoto; Shigeto Yamawaki
Journal:  Nat Neurosci       Date:  2004-07-04       Impact factor: 24.884

2.  Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.

Authors:  Jee-Young Lee; Eun Kyung Lee; Sung Sup Park; Ji-Yeon Lim; Hee Jin Kim; Ji Sun Kim; Beom S Jeon
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

3.  Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance.

Authors:  R D Rogers; C Baunez; B J Everitt; T W Robbins
Journal:  Behav Neurosci       Date:  2001-08       Impact factor: 1.912

4.  Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task.

Authors:  J W Dalley; J McGaughy; M T O'Connell; R N Cardinal; L Levita; T W Robbins
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

Authors:  Evelyn Braungart; Manfred Gerlach; Peter Riederer; Ralf Baumeister; Marius C Hoener
Journal:  Neurodegener Dis       Date:  2004       Impact factor: 2.977

6.  Effects of neostriatal 6-OHDA lesion on performance in a rat sequential reaction time task.

Authors:  D Domenger; R K W Schwarting
Journal:  Neurosci Lett       Date:  2008-08-22       Impact factor: 3.046

7.  Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice.

Authors:  Gregory B Bissonette; Gabriela J Martins; Theresa M Franz; Elizabeth S Harper; Geoffrey Schoenbaum; Elizabeth M Powell
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

8.  Biochemical aspects of Parkinson-dementia complex.

Authors:  S Nakamura; H Fukuda; K Hara; H Fukuyama; M Kameyama
Journal:  Eur Neurol       Date:  1988       Impact factor: 1.710

9.  Inactivation of the infralimbic prefrontal cortex reinstates goal-directed responding in overtrained rats.

Authors:  Etienne Coutureau; Simon Killcross
Journal:  Behav Brain Res       Date:  2003-11-30       Impact factor: 3.332

Review 10.  The role of serotonin in the regulation of patience and impulsivity.

Authors:  Katsuhiko Miyazaki; Kayoko W Miyazaki; Kenji Doya
Journal:  Mol Neurobiol       Date:  2012-01-20       Impact factor: 5.590

View more
  8 in total

1.  Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration.

Authors:  Anandh Dhanushkodi; Yi Xue; Emily E Roguski; Yun Ding; Shannon G Matta; Detlef Heck; Guo-Huang Fan; Michael P McDonald
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

2.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 3.  Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration.

Authors:  Khalid Bashir Dar; Aashiq Hussain Bhat; Shajrul Amin; Bilal Ahmad Reshi; Mohammad Afzal Zargar; Akbar Masood; Showkat Ahmad Ganie
Journal:  Cell Mol Neurobiol       Date:  2019-10-04       Impact factor: 5.046

4.  Thalamic degeneration in MPTP-treated Parkinsonian monkeys: impact upon glutamatergic innervation of striatal cholinergic interneurons.

Authors:  Rosa M Villalba; Jean-Francois Pare; Solah Lee; Sol Lee; Yoland Smith
Journal:  Brain Struct Funct       Date:  2019-11-02       Impact factor: 3.270

5.  Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.

Authors:  Yingjuan Liu; Lihua Geng; Jingjing Zhang; Jing Wang; Qi Zhang; Delin Duan; Quanbin Zhang
Journal:  Mar Drugs       Date:  2018-03-06       Impact factor: 5.118

Review 6.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014

7.  Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice.

Authors:  Yan Liu; Xiaodan Zong; Jie Huang; Yanfei Guan; Yuanquan Li; Ting Du; Keyin Liu; Xinpan Kang; Chunyan Dou; Xiangdong Sun; Renhua Wu; Lei Wen; Yunlong Zhang
Journal:  Aging (Albany NY)       Date:  2019-07-17       Impact factor: 5.682

Review 8.  Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside.

Authors:  Andrea Augustine; Catharine A Winstanley; Vaishnav Krishnan
Journal:  Front Neurosci       Date:  2021-03-12       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.